[1] 蔡琳,GOLDSTEIN B Y,PARKIN D M,et al.东亚地区癌症负担和预防策略[J].肿瘤,2008,28(5):410-414.
[2] ROVIELLO F,MARRELLI D,MORGAGNI P,et al.Italian research group for gastric cancer.Survival benefit of extended D2 lymphadenectomy in gastric cancer with involvement of second level lymph nodes:a longitudinal multicenter study[J].Ann Surg Oncol,2002,9(9):894-900.
[3] ZILBERSTEIN B,da COSTA- MARTINS B,JACOB C E,et al.Complications of gastrectomy with-lymphadenectomy in gastric cancer[J].Gastric Cancer,2004,7(4):254-259.
[4] SONGUN I,PUTTER H,KRANENBARG E M,et al.Surgical treatment of gastric cancer:15 year follow-up results of the randomized nationwide Dutch D1 D2 trial[J].Lancet Oncol,2010,11:439-449.
[5] EDWARDS P,BLACKSHAW P G,BARRY J,et al.Randomized comparison of D1 versus modified D2 gastrectomy for gastric cancer[J].Br J Surg,2004,90:888-1892.
[6] MCCULLOCH P,NITA M E,KAZI H,et al.Withdrawn:extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach[J].Cochrane Database Syst Rev,2012(1):CDOO1964,2008(4).
[7] JANUNGER K G,HAFSTROM L,NYGREN P et al.A systematic overview of chemotherapy effects in gastric cancer[J].Acta Oncol,2001,40(2-3):309-326.
[8] MACDONALD J S,SMALLEY S R,BENEDETTI J,et al.Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastro-esophageal junction[J].N Engl J Med,2001,345:725-730.
[9] LIM D H,KIM D Y,KANG M K,et al.Patterns of failure in gastric carcinoma after D2 gastrectomy and chemoradiotherapy:a radiation oncologist's view[J].Br J Cancer,2004,91:11-17.
[10] KIM S,LIM D H,LEE J,et al.An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach[J].Int J Radiat Oncol Biol Phys,2005,63:1279-1285.
[11] LEONG C N,CHUNG H T,LEE K M,et al.Outcomes of adjuvant chemoradiotherapy after a radical gastrectomy and a D2 node dissection for gastric adenocarcinoma[J].Cancer J,2008,14:269-275.
[12] YU C G,YU R,ZHU W G,et al.Intensity-modulated radiotherapy combined with chemotherapy for the treatment of gastric cancer patients after standard D1/D2 surgery[J].J Cancer Res Clin Oncol,2012 ,138(2):255-259.
[13] ARCANGELI G,SARACINO B,ANGELINI F,et al.Postoperative adjuvant chemoradiation in completely resected locally advanced gastric cancer[J].Int J Radiat Oncol Biol Phys,2002,54:1069-1075.
[14] LEONG T,MICHAEL M,FOO K,et al.Adjuvant and neoadjuvant therapy for gastric cancer using epirubicin/cisplatin/5-fluorouracil(ECF)and alternative regimens before and after chemoradiation[J].Br J Cancer,2003,89:1433-1438.
[15] KASSAM Z,LOCKWOOD G,O'BRIEN C,et al.Conformal radiotherapy in the adjuvant treatment of gastric cancer:review of 82 cases[J].Int J Radiat Oncol Biol Phys,2006,65:713-719.
[16] KWON H C,KIM M C,KIM K H,et al.Adjuvant chemoradiation versus chemotherapy in completely resected advanced gastric cancer with D2 nodal dissection[J].Asia Pac J Clin Oncol,2010,6(4):278-285.
[17] LEE J,LIM D H,KIM S,et al.Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection:the ARTIST trial[J].J Clin Oncol,2012,30(3):268-273.
[18] SHINICHI S,MITSURU S,TOSHIHARU Y,et al.Adjuvant chemotherapy for gastric cancer with s-1,an oral fluoropyrimidine[J].N Engl J Med,2007,357:1810-1820.
[19] BANG Y J,van CUTSEM E,FEYEREISLOVA A,et al.Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER-positive advanced gastric or gastro-oesophageal junction cancer(To-GA):a phase 3,open—label,randomized controlled trial[J].Lancet,2010,376(9742):687-697.
[20] KANG Y K,OHTSU A,van CUTSEM E,et al.AVAGAST:a randomized ,double-blind placebo-controlled phase III study of first-line capecitabine and cisplatin plus bevacizumab or placebo In patients with advanced gastric cancer(AGC)[J].J Clin Oncol,2010,28:18s(abstr LBA4007). |
